Skip to search
Skip to main content
Skip to first result
Maxine Singer - Profiles in Science
Contact
About
Maxine Singer
The Maxine Singer Papers
Home
The Story
Biographical Overview
Nucleic Acids, the Genetic Code, and Transposable Genetic Elements: A Life in Research
Risk, Regulation, and Scientific Citizenship: The Controversy over Recombinant DNA Research
The Science Administrator as Advocate
Additional Resources
Glossary
Collection Items
search for
Search
Search
Home
Search results
Search
Search Constraints
Start Over
You searched for:
Language
English
✖
Remove constraint Language: English
Format
Text
✖
Remove constraint Format: Text
Subject
DNA, Recombinant
✖
Remove constraint Subject: DNA, Recombinant
Exhibit Tags
regulation
✖
Remove constraint Exhibit Tags: regulation
« Previous |
1
-
50
of
53
|
Next »
Sort
by Title (A-Z)
Relevance
Title (A-Z)
Title (Z-A)
Date (oldest to newest)
Date (newest to oldest)
Number of results to display per page
50
per page
per page
10
per page
20
per page
50
per page
100
per page
View results as:
List
List
Gallery
Gallery
Masonry
Masonry
Slideshow
Slideshow
Search Results
×
A Statement
1 of 53
A Summary of the National Institutes of Health (USA) Guidelines for Recombinant DNA Research
2 of 53
Appendix C: Program of the International Conference on Recombinant DNA Molecules
3 of 53
Appendix D: Proposed Guidelines on Potential Biohazards Associated with Experiments Involving Genetically Altered Microorganisms
4 of 53
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
5 of 53
Appendix E: Preparation and Use of Recombinant Molecules Involving Animal Virus Genomes
6 of 53
Appendix F: Cloned Eukaryotic DNA
7 of 53
Appendix F: Cloned Eukaryotic DNA
8 of 53
Appendix H: Provisional Statement of the Conference Proceedings
9 of 53
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
10 of 53
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
11 of 53
Appendix I: Summary Statement of the Asilomar Conference on Recombinant DNA Molecules
12 of 53
Appendix J: A Plausible Model for Monitoring Compliance with Containment Guidelines
13 of 53
Interview with Dr. Maxine F. Singer [on recombinant DNA research and NIH]
14 of 53
Letter from Carolyn E. Kemp to Maxine Singer
15 of 53
Letter from Charles Warren and Barry Keene to Maxine Singer
16 of 53
Letter from David Baltimore to Fred C. Ikle
17 of 53
Letter from David S. Hogness to DeWitt Stetten, Jr
18 of 53
Letter from Joshua Lederberg to U.S. Senators Alan Cranston and Samuel Ichiye Hayakawa
19 of 53
Letter from London Ganning to Maxine Singer
20 of 53
Letter from Maxine Singer to Carolyn E. Kemp
21 of 53
Letter from Maxine Singer to Charles Warren
22 of 53
Letter from Maxine Singer to Donald S. Fredrickson
23 of 53
Letter from Maxine Singer to London Ganning
24 of 53
Letter from Maxine Singer to Lorill Brown-Rezanka
25 of 53
Letter from Maxine Singer to Milton P. Gordon
26 of 53
Letter from Maxine Singer to Robert L. Sinsheimer
27 of 53
Letter from Maxine Singer to U.S. Representative Richard Ottinger
28 of 53
Letter from Maxine Singer to Wallace P. Rowe
29 of 53
Letter from Maxine Singer to Willard Gaylin
30 of 53
Letter from Maxine Singer to William J. Gartland
31 of 53
Letter from Paul Berg to Robert L. Sinsheimer
32 of 53
Letter from Paul Berg to U.S. Senator Harrison Schmitt
33 of 53
Letter from Roy Curtiss III to Donald S. Fredrickson
34 of 53
Letter from Roy Curtiss III to Donald S. Fredrickson
35 of 53
Letter from Roy Curtiss III to Maxine Singer
36 of 53
Letter from Stanley N. Cohen to Maxine Singer
37 of 53
Letter from U.S. Representative Paul G. Rogers to Maxine Singer
38 of 53
Letter from Wallace P. Rowe to Maxine Singer
39 of 53
Memorandum from Allen Silverstone to the Advisory Committee on the Guidelines for Recombinant DNA
40 of 53
Memorandum from Maxine Singer to Donald S. Fredrickson
41 of 53
Memorandum from Maxine Singer to Paul Berg, David Baltimore, Sydney Brenner, and Richard O. Roblin on the latest draft of the Asilomar Reports
42 of 53
Memorandum from Michael Adler [summarizing the first day of hearings of the Thornton House Subcommittee on Science, Research, and Technology]
43 of 53
Memorandum from Paul Berg to the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
44 of 53
Minutes of the Eleventh Meeting of the Executive Recombinant DNA Committee
45 of 53
Open Letter to the Asilomar Conference on Hazards of Recombinant DNA
46 of 53
Ordinance No. 5010: Regulating the Use of Hazardous Biological Research in the City of Berkeley
47 of 53
Ordinance for the Use of Recombinant Molecule Technology in the City of Cambridge
48 of 53
Potential Biohazards of Recombinant DNA Molecules [Letter to the Editor of Science]
49 of 53
Report of the Organizing Committee for the Asilomar Conference on Recombinant DNA Molecules
50 of 53
previous image
next image
Pause Slideshow
Start Slideshow
« Previous
Next »
1
2